|
| ||||||||||||||||||||||||||||||||||||||||||||||||||
Cholesterol in Childhood
Committee on Nutrition |
ABSTRACT |
|---|
 TOP ABSTRACT DIET AND ATHEROSCLEROSISCLINICAL TRIALSSIGNIFICANCE OF BLOOD...STRATEGIES TO LOWER CHOLESTEROL...THE INDIVIDUALIZED APPROACHCONCLUSIONREFERENCES |
|---|
This updated statement reviews the scientific justification for the recommendations of dietary changes in all healthy children (a population approach) and a strategy to identify and treat children who are at highest risk for the development of accelerated atherosclerosis in early adult life (an individualized approach). Although the precise fraction of risk for future coronary heart disease conveyed by elevated cholesterol levels in childhood is unknown, clear epidemiologic and experimental evidence indicates that the risk is significant. Diet changes that lower fat, saturated fat, and cholesterol intake in children and adolescents can be applied safely and acceptably, resulting in improved plasma lipid profiles that, if carried into adult life, have the potential to reduce atherosclerotic vascular disease.
Abbreviations: LDL = low-density lipoprotein • HDL = high-density lipoprotein
Although the focus of this statement by the Committee on Nutrition is on cholesterol levels in children, other risk factors for atherosclerosis originate in childhood and should be addressed with equal attention. Specifically, smoking should be discouraged, hypertension should be identified and treated, obesity should be avoided and reduced, regular exercise should be encouraged, and diabetes mellitus should be identified and treated.1
This statement, for the most part, is in concert with statements of other experts and expert panels, including the National Cholesterol Education Program, the American Heart Association's Council on Cardiovascular Disease in the Young and Committee on Nutrition, the US Department of Agriculture and the US Department of Health and Human Services Dietary Guidelines for Americans, the US Surgeon General, the National Research Council, and the National Cancer Institute.
|
DIET AND ATHEROSCLEROSIS |
|---|
|
TOPABSTRACTDIET AND ATHEROSCLEROSISCLINICAL TRIALSSIGNIFICANCE OF BLOOD...STRATEGIES TO LOWER CHOLESTEROL...THE INDIVIDUALIZED APPROACHCONCLUSIONREFERENCES |
|---|
Studies in animals have demonstrated that high blood cholesterol levels promote atherosclerosis.2-4 Atherosclerosis develops in many species fed diets that raise the total and low-density lipoprotein (LDL)–cholesterol levels. Vascular fatty streaks and fibrous plaques develop in adolescent nonhuman primates fed diets high in saturated fatty acids and cholesterol.56 In monkeys with severe atherosclerosis, regression of the process occurs when the blood cholesterol level is lowered with diet and drugs.278
In adults, the major nutritional determinant of differences in serum cholesterol levels between countries appears to be the proportion of saturated fat in the diet.9-11 This also is observed in childhood populations.11-13 Total blood cholesterol levels in children vary geographically. In countries such as the Philippines, Italy, and Ghana, saturated fat constitutes approximately 
10% dietary intake, and the serum cholesterol level in boys 8 to 9 years of age is generally below 160 mg/dL.13-15 In boys from countries such as the Netherlands, Finland, and the United States, the saturated fat intake varies from 13.5% to 17.7% of energy intake, and serum cholesterol levels are generally >160 mg/dL. Although blood cholesterol levels are lowest in countries in which nutrition is not optimal and growth is delayed, there are many industrialized countries in which children have lower cholesterol levels than children in the United States and in which normal growth is maintained (eg, Portugal, Israel, and Italy). A range of serum cholesterol levels is found in industrialized countries, with the United States in the top half of the range.1315-23
|
CLINICAL TRIALS |
|---|
|
TOPABSTRACTDIET AND ATHEROSCLEROSISCLINICAL TRIALSSIGNIFICANCE OF BLOOD...STRATEGIES TO LOWER CHOLESTEROL...THE INDIVIDUALIZED APPROACHCONCLUSIONREFERENCES |
|---|
Clinical trials in adult populations have shown that lowering cholesterol levels reduces coronary risk.224-26Aggregate analysis of many clinical trials shows that lowering cholesterol levels by diet or drugs and by primary or secondary prevention reduces fatal and nonfatal myocardial infarction.27 Initially, some controversy occurred about the effectiveness of lowering cholesterol levels because a number of trials did not find a significant reduction in total mortality after treatment to lower the cholesterol level.2 These findings have been clarified recently by several studies with large samples of subjects and of long duration showing a decrease not only in the incidence of coronary heart disease but also in mortality from all causes.2829
In addition, the Dietary Intervention Study in Children, a recent study of the safety and efficacy of lower fat diets in pubertal children, was reported by a collaborative multicenter group. In this study of 663 children 8 to 10 years of age who were followed for 3 years, an intervention group receiving a diet with 28% of calories from total fat, 
10% of calories from saturated fat, and 95 mg per day of cholesterol was compared with a group that consumed 33% to 34% of calories as total fat, 12.7% of calories as saturated fat, and 112 mg per day of cholesterol. There were no differences in height, weight, or serum ferritin levels in the two groups, and the intervention group had significant, but modestly lower, levels of LDL–cholesterol levels and maintained psychologic well-being.30
|
SIGNIFICANCE OF BLOOD CHOLESTEROL LEVELS IN CHILDREN AND ADOLESCENTS |
|---|
|
TOPABSTRACTDIET AND ATHEROSCLEROSISCLINICAL TRIALSSIGNIFICANCE OF BLOOD...STRATEGIES TO LOWER CHOLESTEROL...THE INDIVIDUALIZED APPROACHCONCLUSIONREFERENCES |
|---|
High blood cholesterol levels clearly play a role in the development of premature coronary heart disease in adults. This has been established by many laboratory, clinical, pathological, and epidemiologic studies. It has also been shown that lowering blood cholesterol levels in adults results in a significant lowering of coronary heart disease rates and mortality. Because no long-term studies of the relationship of blood cholesterol levels measured in childhood to coronary heart disease in later life have been conducted, the relationship of childhood cholesterol levels to the atherosclerotic process must be inferred from less direct evidence.
These lines of evidence are summarized as follows:
- Compared with their counterparts in many other countries, US children and adolescents have higher blood cholesterol levels and higher intakes of saturated fatty acids and cholesterol, and US adults have higher rates of coronary heart disease morbidity and mortality.1315
- Autopsy studies demonstrate that early coronary atherosclerosis or precursors of atherosclerosis often begin in childhood and adolescence and are related to high serum total cholesterol levels, LDL–cholesterol plus very low-density lipoprotein–cholesterol levels, and low high-density lipoprotein levels.
- Children and adolescents with elevated serum cholesterol levels, particularly LDL–cholesterol levels, often come from families in which there is a high incidence of coronary heart disease in the adult relatives.3233
- A strong familial aggregation of total, LDL-, and HDL–cholesterol levels exists in children and parents.3435 Familial aggregation of blood cholesterol levels results because of shared environments and genetic factors.36 The monogenetic factors that cause high cholesterol levels include familial hypercholesterolemia and familial-combined hypercholesterolemia. Polygenic disorders that result from the expression of a number of genes, each with a small but additional effect, combined with environmental contributions such as a diet high in saturated fat and cholesterol are likely the most frequent causes of high cholesterol levels during childhood.3738
- Children and adolescents with high cholesterol levels are more likely than the general population to have high levels as adults.39-45 However, a substantial number of children with high cholesterol levels become adults with desirable cholesterol levels without intervention.46
|
STRATEGIES TO LOWER CHOLESTEROL LEVELS IN CHILDREN AND ADOLESCENTS |
|---|
|
TOPABSTRACTDIET AND ATHEROSCLEROSISCLINICAL TRIALSSIGNIFICANCE OF BLOOD...STRATEGIES TO LOWER CHOLESTEROL...THE INDIVIDUALIZED APPROACHCONCLUSIONREFERENCES |
|---|
To lower blood cholesterol levels in children and adolescents, two complementary approaches are recommended: a population approach and an individualized approach.
The Population Approach
The population approach is designed as the primary means for preventing coronary heart disease. It aims to lower the average level of blood cholesterol in all children and adolescents through population-wide changes in nutrient intake and eating patterns. These recommendations are directed to groups that influence the eating patterns of children and adolescents, including schools, health professionals, government agencies, the food industry, and the mass media. The advantage of this approach is that even a small reduction of the mean total and LDL–cholesterol levels in children and adolescents, if carried into adult life, could decrease substantially the incidence of coronary heart disease.
The US Department of Agriculture 1987 to 1988 Food Consumption Survey indicated that children and adolescents consume 35% to 36% of calories from total fat; 14% from saturated fat, and 193 to 296 mg per day of cholesterol.4748 More recent US population-based data from the National Health and Nutrition Examination Survey III for persons 2 to 19 years of age indicate that mean intakes of total fat and saturated fat are 34% and 12%, respectively, and the mean cholesterol intake is 270 mg per day.49
Nutrient Recommendations
No restriction of fat or cholesterol is recommended for infants <2 years when rapid growth and development require high energy intakes. A precise percentage of dietary intake from fat that supports normal growth and development while maximally reducing atherosclerosis risk is unknown. Therefore, a range of appropriate values, averaged over several days for a child or adolescent, is recommended based on the scientific information available. Because concerns have been expressed that some parents and their children may overinterpret the need to restrict their fat intakes, a lower limit of fat intake is suggested by this Committee. The Committee recognizes that children 2 to 5 years of age are selective in their food choices. After 2 years of age, children and adolescents should gradually adopt a diet that, by 5 years of age, contains 30% of calories and 20% from fat. As they begin to consume fewer calories from fat, children should replace these calories by eating more grain products, fruits, vegetables, low-fat milk products or other calcium-rich foods, beans, lean meat, poultry, fish, or other protein-rich foods. These recommendations are for average intakes over several days, so that if foods high in total fat, saturated fat, and cholesterol are eaten, they can be compensated for by eating less of these nutrients at other times. Because no single food item provides all the essential nutrients in the amounts needed, choosing a wide variety of food from all the food groups will ensure an adequate diet.
Specific nutrient recommendations are as follows: 1) nutritional adequacy should be achieved by eating a wide variety of foods; and 2) caloric intake should be adequate to support growth and development and to reach or maintain desirable body weight.
For a child or adolescent (2 to 18 years of age), the following pattern of nutrient intake is recommended: 1) saturated fatty acids <10% of total calories; 2) total fat over several days of 30% of total calories and no less than 20% of total calories; and 3) dietary cholesterol <300 mg per day.
Because saturated fatty acids raise blood cholesterol levels,50 a major emphasis should be placed on reducing saturated fat intake to <10% of calories. A sufficiently low saturated fat intake can be achieved with a total fat intake of 30% of calories from fat. A lower fat intake is usually not necessary and, for some children and adolescents, may make it difficult to provide enough calories and minerals for optimal growth and development.
|
THE INDIVIDUALIZED APPROACH |
|---|
|
TOPABSTRACTDIET AND ATHEROSCLEROSISCLINICAL TRIALSSIGNIFICANCE OF BLOOD...STRATEGIES TO LOWER CHOLESTEROL...THE INDIVIDUALIZED APPROACHCONCLUSIONREFERENCES |
|---|
The individualized approach to lowering cholesterol levels calls on the cooperative effort of health care professionals to identify and treat children and adolescents at highest risk of having high blood cholesterol levels as adults and increased risk of coronary heart disease.
Selective Screening
Figures 1 and2 present the algorithms for selective screening.
|
|
Children and adolescents who have a family history of premature cardiovascular disease or have at least one parent with a high blood cholesterol level are at increased risk of having high blood cholesterol levels as adults and increased risk of coronary heart disease and, therefore, are recommended for selective screening in the context of regular health care. This focus is supported by strong evidence of familial aggregation of coronary heart disease, high blood cholesterol levels, and other risk factors.
The following are specific recommendations for selective screening of children and adolescents in the context of their continuing health care.
- Screen children and adolescents whose parents or grandparents, at 55 years of age, underwent diagnostic coronary arteriography and were found to have coronary atherosclerosis. This includes those who have undergone balloon angioplasty or coronary artery bypass surgery.
- Screen children and adolescents whose parents or grandparents, at 55 years of age, had a documented myocardial infarction, angina pectoris, peripheral vascular disease, cerebrovascular disease, or sudden cardiac death.
- Screen the offspring of a parent with an elevated blood cholesterol level (240 mg/dL or higher).
- For children and adolescents whose parental history is unobtainable, particularly for those with other risk factors, physicians may choose to measure cholesterol levels to identify those in need of nutritional and medical advice.
Optional cholesterol testing by practicing physicians may be appropriate for children who are judged to be at higher risk for coronary heart disease independent of family history (Table1). For example, adolescents who smoke, consume excessive amounts of saturated fats and cholesterol, or are overweight may also be tested at the discretion of their physician. For parents who do not know their cholesterol levels, pediatricians should strongly encourage them to have their levels measured.
|
What Should Be Measured
The focus of the individualized approach is to detect and treat the child or adolescent with hypercholesterolemia whose elevated LDL–cholesterol level is likely to indicate increased risk in adulthood. The screening protocol varies according to the reason for testing. This protocol is suggested to limit the need for more sophisticated analyses. If screening is performed because a parent has a cholesterol higher than 240 mg/dL, the initial test should be a measurement of total cholesterol. If the child's level is higher than 200 mg/dL, a fasting lipoprotein analysis should be obtained to measure HDL–cholesterol and LDL–cholesterol levels. If the total cholesterol is borderline (170 to 199 mg/dL), a second measurement should be obtained and averaged with the first result. If the average is borderline or high, a fasting lipoprotein analysis should be obtained.
If the patient is being tested because of a documented family history of premature cardiovascular disease, the initial test should be a lipoprotein analysis that requires a 12-hour fast to obtain accurate triglyceride levels, which are necessary for the computation of LDL–cholesterol levels. The acceptable borderline and high levels for total and LDL–cholesterol are given in Table2.
|
Management
Because there is considerable variability in some children, once a lipoprotein analysis is obtained, it should be repeated so that an average LDL–cholesterol level can be calculated. The average LDL–cholesterol level determines the steps for risk assessment and treatment. Follow-up of the averaged LDL–cholesterol determinations is as follows:
1. Acceptable LDL–cholesterol level (<110 mg/dL)—Provide education on the eating pattern recommended for all children and adolescents and on other risk factors; repeat lipoprotein analysis in 5 years.
2. Borderline LDL–cholesterol (110 to 129 mg/dL)—Provide advice about risk factors for cardiovascular disease; initiate the American Heart Association Step-One diet and other risk factor intervention; reevaluate in 1 year.
3. High LDL–cholesterol (
130 mg/dL)—Examine for secondary causes (thyroid, liver, and renal disorders) and familial disorders, screen all family members, initiate Step-One diet, followed by the Step-Two diet, if necessary.
Step-One and Step-Two Diets
The Step-One diet calls for the same nutrient intake recommended for the population approach to lower cholesterol levels, ie, 30% and no less than 20% of calories from total fat; <10% of total calories from saturated fat; 10% of calories from polyunsaturated fat; and no more than 300 mg per day of cholesterol. What makes the diet therapeutic is prescription in a medical setting with monitoring and follow-up by a health professional. If careful adherence to this diet for at least 3 months does not result in a lower LDL–cholesterol level to the acceptable range, the Step-Two diet should be prescribed. Often children who have been determined to have high LDL–cholesterol levels have instituted a diet similar to the Step-One diet and require counseling to adopt the Step-Two diet.51
The Step-Two diet requires detailed assessment of current eating patterns and instruction by a physician, registered dietitian, registered nurse, nutritionist, or other appropriately trained health professional. It aims to induce an eating pattern that includes no more than 30% and no less than 20% of calories from total fat; <7% of total calories from saturated fat; 10% of calories from polyunsaturated fat; and no more than 200 mg per day of cholesterol. This eating pattern requires careful planning to ensure adequacy of nutrients, vitamins, and minerals, and often requires the services of a registered dietitian or other qualified nutrition professional.
Drug Therapy
Drug therapy should be considered only for children >10 years of age after an adequate trial of diet therapy (for 6 to 12 months) and whose LDL–cholesterol level remains 190 mg/dLor whose LDL–cholesterol level remains 160 mg/dLand there is a family history of premature cardiovascular disease (55 years of age) or two or more other risk factors (Table 1) are present in the child or adolescent after vigorous attempts have been made to control these risk factors.
The recommended drugs for the treatment of hypercholesterolemia and high LDL–cholesterol levels in children are the bile acid sequestrants cholestyramine and colestipol, which bind bile acids in the intestinal lumen. They have documented efficacy, relative freedom from adverse effects, and are apparently safe when administered to children. Other pharmacologic agents are not recommended for routine use in children and adolescents except in consultation with a lipid specialist.
|
CONCLUSION |
|---|
|
TOPABSTRACTDIET AND ATHEROSCLEROSISCLINICAL TRIALSSIGNIFICANCE OF BLOOD...STRATEGIES TO LOWER CHOLESTEROL...THE INDIVIDUALIZED APPROACHCONCLUSIONREFERENCES |
|---|
To promote lower cholesterol levels in all healthy children (2 to 18 years of age) in the United States, the following pattern of nutrient intake is recommended.
- Saturated fatty acids <10% of total calories.
- Total fat over several days of no more than 30% of total calories and no less than 20% of total calories.
- Dietary cholesterol <300 mg per day.
Pediatricians should identify children at highest risk for the development of accelerated atherosclerosis by screening cholesterol levels in children who have a parental or grandparental history (55 years of age) of a documented myocardial infarction, angina pectoris, peripheral vascular disease, cerebrovascular disease, or sudden cardiac death, or a parent with a high blood cholesterol level (240 mg/dL). In addition, for children and adolescents whose parental history is unobtainable, particularly those with other risk factors, physicians may measure cholesterol levels to determine those in need of nutritional and medical advice.
A precise percentage of dietary intake from fat that supports normal growth and development while maximally reducing atherosclerosis risk is unknown. Therefore, a range of appropriate values, averaged over several days for a child or adolescent, is recommended based on the scientific information available.
COMMITTEE ON NUTRITION, 1996 TO 1997
William J. Klish, MD, Chair
Susan S. Baker, MD
William J. Cochran, MD
Carlos A. Flores, MD
Michael K. Georgieff, MD
Marc S. Jacobson, MD
Alan Lake, MD
LIAISON REPRESENTATIVES
Donna Blum
US Department of Agriculture
Suzanne S. Harris, PhD
International Life Sciences Institute
Van S. Hubbard, MD
National Institute of Diabetes & Digestive & Kidney Diseases
Ephraim Levin, MD
National Institute of Child Health & Human Development
Ann Prendergast, RD, MPH
Maternal & Child Health Bureau
Alice E. Smith, MS, RD
American Dietetic Association
Elizabeth Yetley, PhD
Food and Drug Administration
AAP SECTION LIAISON
Ronald M. Lauer, MD
Section on Cardiology
|
FOOTNOTES |
|---|
Material in this statement is adapted from the Report of the Expert Panel on Blood Cholesterol in Children and Adolescentsof the National Cholesterol Education Program.52It has been modified to reflect additional considerations of the Committee on Nutrition of the American Academy of Pediatrics.
The recommendations in this statement do not indicate an exclusive course of treatment or serve as a standard of medical care. Variations, taking into account individual circumstances, may be appropriate.
|
REFERENCES |
|---|
|
TOPABSTRACTDIET AND ATHEROSCLEROSISCLINICAL TRIALSSIGNIFICANCE OF BLOOD...STRATEGIES TO LOWER CHOLESTEROL...THE INDIVIDUALIZED APPROACHCONCLUSIONREFERENCES |
|---|
- Strong WB, Deckelbaum RJ, Gidding SS, et al, Integrated cardiovascular health promotion in childhood: a statement for health professionals from the Subcommittee on Atherosclerosis and Hypertension in Childhood of the Council on Cardiovascular Disease in the Young, American Heart Association.Circulation.85, 1992, 1638, 1650
[Free Full Text] - LaRosa JC, Hunninghake D, Bush D, et al, The cholesterol facts: a summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute.Circulation.81, 1990, 1721, 1733
[Free Full Text] - Bullock BC, Lehner ND, Clarkson TB, Feldner MA, Wagner WD, Lofland HB, Comparative primate atherosclerosis. I. Tissue cholesterol concentration and pathologic anatomy.Exp Mol Pathol.22, 1975, 151, 175[CrossRef][Medline]
- Taylor CB, Patton DE, Cox GE, Atherosclerosis in rhesus monkeys. VI. Fatal myocardial infarction in a monkey fed fat and cholesterol.Arch Pathol.76, 1963, 404, 412[Medline]
- Clarkson TB, Bond MG, Bullock BC, Marzetta CA, A study of atherosclerosis regression in Macaca mulatta. IV. Changes in coronary arteries from animals with atherosclerosis induced for 19 months and then regressed for 24 or 48 months at plasma cholesterol concentrations of 300 or 200 mg/dL.Exp Mol Pathol.34, 1981, 345, 368[CrossRef][Medline]
- Clarkson TB, Bond MG, Bullock BC, McLaughlin KJ, Sawyer JK, A study of atherosclerosis regression in Macaca mulatta. V. Changes in abdominal aorta and carotid and coronary arteries from animals with atherosclerosis induced for 38 months and then regressed for 24 or 48 months at plasma cholesterol concentrations of 300 or 200 mg/dL.Exp Mol Pathol.41, 1984, 96, 118[CrossRef][Medline]
- Armstrong ML, Regression of atherosclerosis.Atherosclerosis Rev.1, 1976, 137, 182
- Malinow MR, Experimental models of atherosclerosis regression.Atherosclerosis.48, 1983, 105, 118[CrossRef][Medline]
- Conference on the health effects of blood lipids: optimal distributions for populations, Workshop report: epidemiological section, American Health Foundation, April 11 and 12, 1979.Prev Med.8, 1979, 612, 678[CrossRef][Medline]
- Coronary heart disease in seven countriesCirculation.41, 1970, I1, I195[Medline]
- Knuiman JT, West CE, Katan MB, Hautvast JG, Total cholesterol and high density lipoprotein cholesterol levels in populations differing in fat and carbohydrate intake.Arteriosclerosis.7, 1987, 612, 619
[Abstract/Free Full Text] - Blackburn H, Diet and atherosclerosis: epidemiologic evidence and public health implications.Prev Med.12, 1983, 2, 10[CrossRef][Medline]
- Knuiman JT, Westenbrink S, van der Heyden L, et al, Determinants of total and high density lipoprotein cholesterol in boys from Finland, the Netherlands, Italy, the Philippines and Ghana with special reference to diet.Hum Nutr Clin Nutr37, 1983, 237, 254[Medline]
- Carroll MD, Abraham S, Dresser CM. Dietary intake source data: United States, 1976–80. Vital health stat 11. 1983; 231
- Abraham S, Johnson CL, Carroll MD. Total Serum Cholesterol Levels of Children 4–17 Years: United States, 1971–74. Hyattsville, MD: US Dept of Health, Education, and Welfare publication PHS 78-1655; 1978
- Knuiman JT, Hermus RJ, Hautvast JG, Serum total and high density lipoprotein (HDL) cholesterol concentrations in rural and urban boys from 16 countries.Atherosclerosis.36, 1980, 529, 537[CrossRef][Medline]
- Halfon ST, Rifkind BM, Harlap S, et al, Plasma lipids and lipoproteins in adult Jews of different origins: the Jerusalem Lipid Research Clinic Prevalence Study.Isr J Med Sci.18, 1982, 1113, 1120[Medline]
- World Health Organization. World Health Statistics Annual, 1986. Geneva, Switzerland: World Health Organization; 1986
- World Health Organization. World Health Statistics Annual, 1987. Geneva, Switzerland: World Health Organization; 1987
- World Health Organization. World Health Statistics Annual, 1988. Geneva, Switzerland: World Health Organization; 1988
- Halfon ST, Eisenberg S, Tamir D, Stein Y, Risk factors for coronary heart disease among Jerusalem school children: preliminary findings.Prev Med.12, 1983, 421, 429[CrossRef][Medline]
- National Center for Health Statistics—National Heart, Lung, and Blood Institute Collaborative Lipid Group, Trends in serum cholesterol levels among US adults aged 20 to 74 years: data from the National Health and Nutrition Examination Surveys, 1960 to 1980.JAMA.257, 1987, 937, 942
[Abstract/Free Full Text] - Knuiman JT, West CE, Burema J, Serum total and high density lipoprotein cholesterol concentrations and body mass index in adult men from 13 countries.Am J Epidemiol.116, 1982, 631, 642
[Abstract/Free Full Text] - Multiple Risk Factor Intervention Trial Research Group, Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial: findings related to a priori hypotheses of the trial.JAMA.263, 1990, 1795, 1801
[Abstract/Free Full Text] - The Lipid Research Clinics Coronary Primary Prevention Trial Results, II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering.JAMA.251, 1984, 365, 374
[Abstract/Free Full Text] - The Lipid Research Clinics Coronary Primary Prevention Trial Results, I. Reduction in incidence of coronary heart disease.JAMA.251, 1984, 351, 364
[Abstract/Free Full Text] - Yusuf S, Wittes J, Friedman L, Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification.JAMA.260, 1988, 2259, 2263
[Abstract/Free Full Text] - Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvistatin Survival Study(4S)Lancet.344, 1994, 1383, 1389[CrossRef][Medline]
- Shepherd J, Cobbe SM, Ford I, et al, Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia.N Engl J Med.333, 1995, 1301, 1307[CrossRef][Medline]
- The Writing Group for the DISC Collaborative Research Group, Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated LDL lipoprotein cholesterol.JAMA.273, 1995, 1429, 1435
[Abstract/Free Full Text] - Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentration and smoking: a preliminary report from the Pathological Determinants of Atherosclerosis in Youth (PDAY) Research GroupJAMA.264, 1990, 3018, 3024
[Abstract/Free Full Text] - Schrott HG, Clarke WR, Abrahams P, Wiebe DA, Lauer RM, Coronary artery disease mortality in relatives of hypertriglyceridemic school children: the Muscatine study.Circulation.65, 1982, 300, 305
[Abstract/Free Full Text] - Moll PP, Sing CF, Weidman WH, et al, Total cholesterol and lipoproteins in school children: prediction of coronary heart disease in adult relatives.Circulation.67, 1983, 127, 134
[Abstract/Free Full Text] - Beaty TH, Self SG, Chase GA, Kwiterovich PO, Assessment of variance components models on pedigrees using cholesterol, low-density, and high-density lipoprotein measurements.Am J Med Genet.16, 1983, 117, 129[CrossRef][Medline]
- Van Natta PA, Jenkins JA, Chase GA, Alvaro K, Bachorik PS, Kwiterovich PO, Jr, The East Baltimore Study. II. Familial aggregation of plasma lipid levels in juveniles in a black inner-city population.Am J Epidemiol.114, 1981, 385, 397
[Abstract/Free Full Text] - Boehnke M, Moll PP, Lange K, Weidman WH, Kottke BA, Univariate and bivariate analyses of cholesterol and triglyceride levels in pedigrees.Am J Med Genet.23, 1986, 775, 792[CrossRef][Medline]
- Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG, Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia.J Clin Invest.52, 1973, 1544, 1568[Medline]
- Kwiterovich PO, Jr, Pediatric implications of heterozygous familial hypercholesterolemia: screening and dietary treatment.Arteriosclerosis.9, 1989, I111, I120
- Clark DA, Allen MF, Wilson FH, Longitudinal study of serum lipids: 12-year report.Am J Clin Nutr.20, 1967, 743, 752[Abstract]
- Clarke WR, Schrott HG, Leaverton PE, Connor WE, Lauer RM, Tracking of blood lipids and blood pressures in school age children: the Muscatine study.Circulation.58, 1978, 626, 634
[Abstract/Free Full Text] - Frerichs RR, Webber LS, Voors AW, Srinivasan SR, Berenson GS, Cardiovascular disease risk factor variables in children at two successive years: the Bogalusa heart study.J Chronic Dis.32, 1979, 251, 262[CrossRef][Medline]
- Laskarzewski P, Morrison JA, deGroot I, et al, Lipid and lipoprotein tracking in 108 children over a four-year period.Pediatrics.64, 1979, 584, 591
[Abstract/Free Full Text] - Freedman DS, Shear CL, Srinivasan SR, Webber LS, Berenson GS, Tracking of serum lipids and lipoproteins in children over an 8-year period: the Bogalusa heart study.Prev Med.14, 1985, 203, 216[CrossRef][Medline]
- Orchard TJ, Donahue RP, Kuller LH, Hodge PN, Drash AL, Cholesterol screening in childhood: does it predict adult hypercholesterolemia? The Beaver County experience.J Pediatr.103, 1983, 687, 691[CrossRef][Medline]
- Lauer RM, Lee J, Clarke WR, Factors affecting the relationship between childhood and adult cholesterol levels: the Muscatine study.Pediatrics.82, 1988, 309, 318
[Abstract/Free Full Text] - Lauer RM, Clarke WR, Use of cholesterol measurements in childhood for the prediction of adult hypercholesterolemia. The Muscatine study.JAMA.264, 1990, 3034, 3038
[Abstract/Free Full Text] - Nationwide Food Consumption Survey, Continuing Survey of Food Intakes by Individuals: Women 19–50 Years and Their Children 1–5 Years. Hyattsville, MD: US Dept of Agriculture, Human Nutrition Information Service, Nutrition Monitoring Division; 1986
- Nationwide Food Consumption Survey, Continuing Survey of Food Intakes by Individuals: Men 19–50 Years. Hyattsville, MD: US Dept of Agriculture, Human Nutrition Information Service, Nutrition Monitoring Division; 1985
- McDowell MA, Briefel RR, Alaimo K, et al. Energy and Macronutrient Intakes of Persons Ages 2 Months and Over in the United States: Third National Health and Nutrition Examination Survey, Phase 1, 1988–91. Hyattsville, MD: National Center for Health Statistics; Advance Data from Vital and Health Statistics; No. 255; 1994
- National Cholesterol Education Program. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction. Bethesda, MD: National Cholesterol Education Program; 1990
- Quivers ES, Driscoll DJ, Garvey CD, et al, Variability in response to a low-fat low-cholesterol diet in children with elevated LDL–cholesterol levels.Pediatrics.89, 1992, 925, 929
[Abstract/Free Full Text] - National Cholesterol Education Program. Report of the Expert Panel on Blood Cholesterol in Children and Adolescents. Bethesda, MD: National Cholesterol Education Program; 1991
PEDIATRICS (ISSN 1098-4275). ©1998 by the American Academy of Pediatrics
This article has been cited by other articles:
 |
|
 |
|
  D. C. Grossman, V. A. Moyer, B. M. Melnyk, R. Chou, T. G. DeWitt, and for the US Preventive Services Task Force The Anatomy of a US Preventive Services Task Force Recommendation: Lipid Screening for Children and Adolescents Arch Pediatr Adolesc Med, March 1, 2011; 165(3): 205 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Holl, S. S. Jaser, J. A. Womack, V. L. Jefferson, and M. Grey Metabolic Risk and Health Behaviors in Minority Youth at Risk for Type 2 Diabetes Diabetes Care, January 1, 2011; 34(1): 193 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Ritchie, E. C.- S. Murphy, C. Ice, L. A. Cottrell, V. Minor, E. Elliott, and W. Neal Universal Versus Targeted Blood Cholesterol Screening Among Youth: The CARDIAC Project Pediatrics, August 1, 2010; 126(2): 260 - 265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. L. Hardy, E. Denney-Wilson, A. P. Thrift, A. D. Okely, and L. A. Baur Screen Time and Metabolic Risk Factors Among Adolescents Arch Pediatr Adolesc Med, July 1, 2010; 164(7): 643 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. E. Delvin, M. Lambert, E. Levy, J. O'Loughlin, S. Mark, K. Gray-Donald, and G. Paradis Vitamin D Status Is Modestly Associated with Glycemia and Indicators of Lipid Metabolism in French-Canadian Children and Adolescents J. Nutr., May 1, 2010; 140(5): 987 - 991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A E Feldstein, P Charatcharoenwitthaya, S Treeprasertsuk, J T Benson, F B Enders, and P Angulo The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years Gut, November 1, 2009; 58(11): 1538 - 1544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Skinner, M. L. Mayer, K. Flower, E. M. Perrin, and M. Weinberger Using BMI to Determine Cardiovascular Risk in Childhood: How Do the BMI Cutoffs Fare? Pediatrics, November 1, 2009; 124(5): e905 - e912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Cox, D. R. Halloran, S. M. Homan, S. Welliver, and D. E. Mager Trends in the Prevalence of Chronic Medication Use in Children: 2002-2005 Pediatrics, November 1, 2008; 122(5): e1053 - e1061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. van der Graaf, C. Cuffie-Jackson, M. N. Vissers, M. D. Trip, C. Gagne, G. Shi, E. Veltri, H. J. Avis, and J. J.P. Kastelein Efficacy and Safety of Coadministration of Ezetimibe and Simvastatin in Adolescents With Heterozygous Familial Hypercholesterolemia J. Am. Coll. Cardiol., October 21, 2008; 52(17): 1421 - 1429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Flouris, B. E. Faught, and P. Klentrou Cardiovascular disease risk in adolescent smokers: evidence of a `smoker lifestyle' J Child Health Care, September 1, 2008; 12(3): 221 - 231. [Abstract] [PDF]
|
|
|
|
|
|
S. R. Daniels, F. R. Greer, and and the Committee on Nutrition Lipid Screening and Cardiovascular Health in Childhood Pediatrics, July 1, 2008; 122(1): 198 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Denney-Wilson, L. L. Hardy, T. Dobbins, A. D. Okely, and L. A. Baur Body Mass Index, Waist Circumference, and Chronic Disease Risk Factors in Australian Adolescents Arch Pediatr Adolesc Med, June 1, 2008; 162(6): 566 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G. Magnussen, O. T. Raitakari, R. Thomson, M. Juonala, D. A. Patel, J. S.A. Viikari, J. Marniemi, S. R. Srinivasan, G. S. Berenson, T. Dwyer, et al. Utility of Currently Recommended Pediatric Dyslipidemia Classifications in Predicting Dyslipidemia in Adulthood: Evidence From the Childhood Determinants of Adult Health (CDAH) Study, Cardiovascular Risk in Young Finns Study, and Bogalusa Heart Study Circulation, January 1, 2008; 117(1): 32 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Velasquez-Mieyer, C. P. Neira, R. Nieto, and P. A. Cowan Review: Obesity and cardiometabolic syndrome in children Therapeutic Advances in Cardiovascular Disease, October 1, 2007; 1(1): 61 - 81. [Abstract] [PDF]
|
|
|
|
 |
|
 E. T. Rhodes, C. B. Ebbeling, A. F. Meyers, C. T. Bayerl, W. L. Ooi, M. F. Bettencourt, and D. S. Ludwig Pediatric Obesity Management: Variation by Specialty and Awareness of Guidelines Clinical Pediatrics, July 1, 2007; 46(6): 491 - 504. [Abstract] [PDF]
|
|
|
|
|
|
E. M. Haney, L. H. Huffman, C. Bougatsos, M. Freeman, R. D. Steiner, and H. D. Nelson Screening and Treatment for Lipid Disorders in Children and Adolescents: Systematic Evidence Review for the US Preventive Services Task Force Pediatrics, July 1, 2007; 120(1): e189 - e214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. de Ferranti, D. Shapiro, R. Markowitz, E. Neufeld, N. Rifai, and H. Bernstein Nonfasting Low-Density Lipoprotein Testing: Utility for Cholesterol Screening in Pediatric Primary Care Clinical Pediatrics, June 1, 2007; 46(5): 441 - 445. [Abstract] [PDF]
|
|
|
|
 |
|
 A. D Flouris, C. H Canham, B. E Faught, and P. Klentrou Prevalence of cardiovascular disease risk in Ontario adolescents Arch. Dis. Child., June 1, 2007; 92(6): 521 - 523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Belay, P. F. Belamarich, and C. Tom-Revzon The Use of Statins in Pediatrics: Knowledge Base, Limitations, and Future Directions Pediatrics, February 1, 2007; 119(2): 370 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Kim, J. Park, H.-S. Kim, D. H. Kim, and S. H. Park Obesity and Cardiovascular Risk Factors in Korean Children and Adolescents Aged 10-18 Years from the Korean National Health and Nutrition Examination Survey, 1998 and 2001 Am. J. Epidemiol., October 15, 2006; 164(8): 787 - 793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Sirikulchayanonta, P. Pavadhgul, R. Chongsuwat, and S. Srisorrachata A preliminary study of hyperlipidemia in Bangkok school children Asia Pac J Public Health, September 1, 2006; 18(3): 15 - 19. [PDF]
|
|
|
|
|
|
M. L. Stone, M. E. Craig, A. K. Chan, J. W. Lee, C. F. Verge, and K. C. Donaghue Natural History and Risk Factors for Microalbuminuria in Adolescents With Type 1 Diabetes: A longitudinal study. Diabetes Care, September 1, 2006; 29(9): 2072 - 2077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Friedman, J. A. Morrison, S. R. Daniels, W. F. McCarthy, and D. L. Sprecher Sensitivity and Specificity of Pediatric Lipid Determinations for Adult Lipid Status: Findings From the Princeton Lipid Research Clinics Prevalence Program Follow-up Study Pediatrics, July 1, 2006; 118(1): 165 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Srinivasan, M. G. Frontini, J. Xu, and G. S. Berenson Utility of Childhood Non-High-Density Lipoprotein Cholesterol Levels in Predicting Adult Dyslipidemia and Other Cardiovascular Risks: The Bogalusa Heart Study Pediatrics, July 1, 2006; 118(1): 201 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Resino, R. Resino, D. Micheloud, D. Gurbindo-Gutierrez, J. A. Leon, J. T. Ramos, L. Ciria, I. de Jose, J. Mellado, A. Munoz-Fernandez, et al. Long-Term Effects of Highly Active Antiretroviral Therapy in Pretreated, Vertically HIV Type 1-Infected Children: 6 Years of Follow-Up Clinical Infectious Diseases, March 15, 2006; 42(6): 862 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Castro-Gago, M. I. Novo-Rodriguez, M. O. Blanco-Barca, A. Urisarri-Ruiz de Cortazar, J. Rodriguez-Garcia, S. Rodriguez-Segade, and J. Eiris-Punal Evolution of Serum Lipids and Lipoprotein (a) Levels in Epileptic Children Treated With Carbamazepine, Valproic Acid, and Phenobarbital J Child Neurol, January 1, 2006; 21(1): 48 - 53. [Abstract] [PDF]
|
|
|
|
 |
|
 J. T. Mallare, A. H. Karabell, P. Velasquez-Mieyer, S. R.S. Stender, and M. L. Christensen Current and Future Treatment of Metabolic Syndrome and Type 2 Diabetes in Children and Adolescents Diabetes Spectr, October 1, 2005; 18(4): 220 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhang, J. R. Hebert, and M. F. Muldoon Dietary Fat Intake Is Associated with Psychosocial and Cognitive Functioning of School-Aged Children in the United States J. Nutr., August 1, 2005; 135(8): 1967 - 1973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Boyd, J. Koenigsberg, B. Falkner, S. Gidding, and S. Hassink Effect of Obesity and High Blood Pressure on Plasma Lipid Levels in Children and Adolescents Pediatrics, August 1, 2005; 116(2): 442 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ishinaga, A. Ueda, T. Mochizuki, S. Sugiyama, and T. Kobayashi Cholesterol Intake Is Associated with Lecithin Intake in Japanese People J. Nutr., June 1, 2005; 135(6): 1451 - 1455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L Braunschweig, S. Gomez, H. Liang, K. Tomey, B. Doerfler, Y. Wang, C. Beebe, and R. Lipton Obesity and risk factors for the metabolic syndrome among low-income, urban, African American schoolchildren: the rule rather than the exception? Am J Clin Nutr, May 1, 2005; 81(5): 970 - 975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhang, M. F. Muldoon, R. E. McKeown, and S. P. Cuffe Association of Serum Cholesterol and History of School Suspension among School-age Children and Adolescents in the United States Am. J. Epidemiol., April 1, 2005; 161(7): 691 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Quattrin, E. Liu, N. Shaw, B. Shine, and E. Chiang Obese Children Who Are Referred to the Pediatric Endocrinologist: Characteristics and Outcome Pediatrics, February 1, 2005; 115(2): 348 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. B. Newman If It's Not Worth Doing, It's Not Worth Doing Well Pediatrics, January 1, 2005; 115(1): 196 - 196. [Full Text] [PDF]
|
|
|
|
 |
|
 W. A Prescott Jr, D.-a. D Streetman, and D. S Streetman The Potential Role of HMG-CoA Reductase Inhibitors in Pediatric Nephrotic Syndrome Ann. Pharmacother., December 1, 2004; 38(12): 2105 - 2114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Sankar Initial treatment of epilepsy with antiepileptic drugs: Pediatric issues Neurology, November 23, 2004; 63(10_suppl_4): S30 - S39. [Abstract] [Full Text]
|
|
|
|
|
|
J. O'Loughlin, B. Lauzon, G. Paradis, J. Hanley, E. Levy, E. Delvin, and M. Lambert Usefulness of the American Academy of Pediatrics Recommendations for Identifying Youths With Hypercholesterolemia Pediatrics, June 1, 2004; 113(6): 1723 - 1727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Boynton-Jarrett, T. N. Thomas, K. E. Peterson, J. Wiecha, A. M. Sobol, and S. L. Gortmaker Impact of Television Viewing Patterns on Fruit and Vegetable Consumption Among Adolescents Pediatrics, December 1, 2003; 112(6): 1321 - 1326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gahagan, J. Silverstein, Committee on Native American Child Health, and Section on Endocrinology Prevention and Treatment of Type 2 Diabetes Mellitus in Children, With Special Emphasis on American Indian and Alaska Native Children Pediatrics, October 1, 2003; 112(4): e328 - e328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Kant Reported Consumption of Low-Nutrient-Density Foods by American Children and Adolescents: Nutritional and Health Correlates, NHANES III, 1988 to 1994 Arch Pediatr Adolesc Med, August 1, 2003; 157(8): 789 - 796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cook, M. Weitzman, P. Auinger, M. Nguyen, and W. H. Dietz Prevalence of a Metabolic Syndrome Phenotype in Adolescents: Findings From the Third National Health and Nutrition Examination Survey, 1988-1994 Arch Pediatr Adolesc Med, August 1, 2003; 157(8): 821 - 827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Committee on Nutrition Prevention of Pediatric Overweight and Obesity Pediatrics, August 1, 2003; 112(2): 424 - 430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
American Diabetes Association Management of Dyslipidemia in Children and Adolescents With Diabetes Diabetes Care, July 1, 2003; 26(7): 2194 - 2197. [Full Text] [PDF]
|
|
|
|
 |
|
 V. O. Shah, M. Scavini, C. A. Stidley, F. Tentori, T. K. Welty, J. W. MacCluer, A. S. Narva, A. Bobelu, C. P. Albert, D. S. Kessler, et al. Epidemic of Diabetic and Nondiabetic Renal Disease among the Zuni Indians: The Zuni Kidney Project J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1320 - 1329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Allard, E. E. Delvin, G. Paradis, J. A. Hanley, J. O'Loughlin, C. Lavallee, E. Levy, and M. Lambert Distribution of Fasting Plasma Insulin, Free Fatty Acids, and Glucose Concentrations and of Homeostasis Model Assessment of Insulin Resistance in a Representative Sample of Quebec Children and Adolescents Clin. Chem., April 1, 2003; 49(4): 644 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Srinivasan, L. Myers, and G. S. Berenson Distribution and Correlates of Non-High-Density Lipoprotein Cholesterol in Children: The Bogalusa Heart Study Pediatrics, September 1, 2002; 110(3): e29 - e29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Gulesserian and K. Widhalm Effect of a Rapeseed Oil Substituting Diet on Serum Lipids and Lipoproteins in Children and Adolescents with Familial Hypercholesterolemia J. Am. Coll. Nutr., April 1, 2002; 21(2): 103 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Williams, M. C. Bollella, B. A. Strobino, A. Spark, T. A. Nicklas, L. B. Tolosi, and B. P. Pittman "Healthy-Start": Outcome of an Intervention to Promote a Heart Healthy Diet in Preschool Children J. Am. Coll. Nutr., February 1, 2002; 21(1): 62 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Franz, J. P. Bantle, C. A. Beebe, J. D. Brunzell, J.-L. Chiasson, A. Garg, L. A. Holzmeister, B. Hoogwerf, E. Mayer-Davis, A. D. Mooradian, et al. Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications Diabetes Care, January 1, 2002; 25(1): 148 - 198. [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Buckley Long-Term Breastfeeding: Nourishment or Nurturance? J Hum Lact, November 1, 2001; 17(4): 304 - 312. [Abstract] [PDF]
|
|
|
|
|
|
Y. Lee, D. C. Mitchell, H. Smiciklas-Wright, and L. L. Birch Diet Quality, Nutrient Intake, Weight Status, and Feeding Environments of Girls Meeting or Exceeding Recommendations for Total Dietary Fat of the American Academy of Pediatrics Pediatrics, June 1, 2001; 107(6): e95 - e95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Gidding;, T. B. Newman, and A. M. Garber Cholesterol Guidelines Debate Pediatrics, May 1, 2001; 107(5): 1229 - 1230. [Full Text]
|
|
|
|
 |
|
 I. C. Baric, S. Cvjetic, and Z. Satalic Dietary Intakes among Croatian Schoolchildren and Adolescents Nutrition and Health, April 1, 2001; 15(2): 127 - 138. [Abstract] [PDF]
|
|
|
|
|
|
G H. Anderson and S. H Zlotkin Developing and implementing food-based dietary guidance for fat in the diets of children Am J Clin Nutr, November 1, 2000; 72(5): 1404S - 1409S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M Bier, R. M Lauer, and O. Simell Summary Am J Clin Nutr, November 1, 2000; 72(5): 1410S - 1413S. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Rask-Nissila, E. Jokinen, P. Terho, A. Tammi, H. Lapinleimu, T. Ronnemaa, J. Viikari, R. Seppanen, T. Korhonen, J. Tuominen, et al. Neurological Development of 5-Year-Old Children Receiving a Low-Saturated Fat, Low-Cholesterol Diet Since Infancy: A Randomized Controlled Trial JAMA, August 23, 2000; 284(8): 993 - 1000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Picciano, H. Smiciklas-Wright, L. L. Birch, D. C. Mitchell, L. Murray-Kolb, and K. L. McConahy Nutritional Guidance Is Needed During Dietary Transition in Early Childhood Pediatrics, July 1, 2000; 106(1): 109 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. B. Newman and A. M. G. MD Cholesterol Screening in Children and Adolescents Pediatrics, March 1, 2000; 105(3): 637 - 638. [Full Text] [PDF]
|
|
|
|
|
|
T. A. Nicklas, L. L. Myers, C. O'Neil, and N. Gustafson Impact of Dietary Fat and Fiber Intake on Nutrient Intake of Adolescents Pediatrics, February 1, 2000; 105(2): e21 - e21. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. McBean and G. D. Miller Enhancing the Nutrition of America's Youth J. Am. Coll. Nutr., December 1, 1999; 18(6): 563 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Milner and R. G. Allison The Role of Dietary Fat in Child Nutrition and Development: Summary of an ASNS Workshop J. Nutr., November 1, 1999; 129(11): 2094 - 2105. [Full Text]
|
|
|
|
|
|
R. J. Deckelbaum, E. A. Fisher, M. Winston, S. Kumanyika, R. M. Lauer, F. X. Pi-Sunyer, S. St. Jeor, E. J. Schaefer, and I. B. Weinstein Summary of a Scientific Conference on Preventive Nutrition: Pediatrics to Geriatrics Circulation, July 27, 1999; 100(4): 450 - 456. [Full Text] [PDF]
|
|
|
|
|
|
D. S. Freedman, W. H. Dietz, S. R. Srinivasan, and G. S. Berenson The Relation of Overweight to Cardiovascular Risk Factors Among Children and Adolescents: The Bogalusa Heart Study Pediatrics, June 1, 1999; 103(6): 1175 - 1182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Groziak and G. D. Miller Dietary Guidelines for Children: Where Are We Heading? J. Nutr., October 1, 1998; 128(10): 1836 - 1838. [Full Text]
|
|
|
|
|
|
H. Lagstrom, H. Niinikoski, H. Lapinleimu, J. Viikari, T. Ronnemaa, O. Simell, N. Ressler, and G. S. Berenson Modifying Coronary Heart Disease Risk Factors in Children: Is It Ever Too Early to Start? JAMA, April 22, 1998; 279(16): 1261 - 1262. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||